Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam in pediatric epilepsy
NCT01364597Phase 3Completed
- Sponsor
- UCB
- Start
- Aug 2011
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of brivaracetam in epilepsy, sponsored by UCB. Started Aug 2011; status: completed.
02
Drugs
brivaracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT01364597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01364597.